Dr.rer.nat. Karin Jöhrer-Deym


list of publications

Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.

Jöhrer K, Obkircher M, Neureiter D, Parteli J, Zelle-Rieser C, Maizner E, Kern J, Hermann M, Hamacher F, Merkel O, Wacht N, Zidorn C, Scheideler M, Greil R.

Mol Med (Berl). 1 Jun 2012; 90(6)681-93.

Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?

Jöhrer K, Hofbauer SW, Zelle-Rieser C, Greil R, Hartmann TN.

Expert Opin Biol Ther. 1 Apr 2012; 12(4)425-41.

Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.

Jöhrer K, Obkircher M, Neureiter D, Parteli J, Zelle-Rieser C, Maizner E, Kern J, Hermann M, Hamacher F, Merkel O, Wacht N, Zidorn C, Scheideler M, Greil R.

J Mol Med (Berl) 29 Dec 2011; ().

Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.

Hofbauer SW, Piñón JD, Brachtl G, Haginger L, Wang W, Jöhrer K, Tinhofer I, Hartmann TN, Greil R.

Cancer Res. 7 Sep 2010; 70(18)7336-44.

The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.

Nevo I, Sagi-Assif O, Meshel T, Ben-Baruch A, Jöhrer K, Greil R, Trejo LE, Kharenko O, Feinmesser M, Yron I, Witz IP.

Cancer Lett 8 Jan 2009; 273(1)127-39.

Tumour-immune cell interactions modulated by chemokines.

Jöhrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R.

Expert Opin Biol Ther. 22 Dec 2008; 8(3)269-90.

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

Falkensammer C, Johrer K, Gander H, Ramoner R, Putz T, Rahm A, Greil R, Bartsch G, Thurnher M.

Cancer Immunol Immunother. 28 Jan 2006; 28-1-2006()1-10.

Polyacetylenes from the Apiaceae vegetables carrot, celery, fennel, parsley, and parsnip and their cytotoxic activities.

Zidorn C, Johrer K, Ganzera M, Schubert B, Sigmund EM, Mader J, Greil R, Ellmerer EP, Stuppner H.

J Agric Food Chem. 6 Apr 2005; 53(7)2518-23.

Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

Johrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, Gander H, Holtl L, Bartsch G, Greil R, Thurnher M.

Clin Cancer Res. 1 Apr 2005; 11(7)2459-65.

Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1.

Johrer K, Janke K, Krugmann J, Fiegl M, Greil R.

Clin Cancer Res. 15 Mar 2004; 10(6)1901-10.

Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.

Greil R, Anether G, Johrer K, Tinhofer I.

J Leukoc Biol. 1 Sep 2003; 74(3)311-30.

Tuning the rheostat of the myelopoietic system via Fas and TRAIL.

Greil R, Anether G, Johrer K, Tinhofer I.

Crit Rev Immunol. 1 Jan 2003; 23(4)301-22.